Literature DB >> 6454082

Suppressor cell activity in multiple sclerosis.

W C Wallen, S A Houff, M Iivanainen, V P Calabrese, G H DeVries.   

Abstract

Patients with multiple sclerosis and matched controls were tested for lymphocyte stimulation response and induction of suppressor cell activity in response to concanavalin A (Con A) and antigens from axolemma or myelin. Of 17 stable patients, 6 failed to have a suppressor cell response activated by one of these brain cell antigens. Among the patients who lacked these suppressor responses, five had lymphocyte stimulation responses to the same antigens. All matched controls except for one had suppressor cell responses to these antigens and none responded with a positive cellular immune reaction. We found no difference in lymphoproliferative responses to Con A in patients and controls. The level of suppressor cell activity induced by Con A in the stable MS patients varied but did not differ significantly from that of controls.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6454082     DOI: 10.1212/wnl.31.6.668

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Peripheral blood lymphocyte phenotype and function in multiple sclerosis.

Authors:  P J Hughes; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-09       Impact factor: 10.154

2.  The influence of disease activity on the number of blood cells of multiple sclerosis patients.

Authors:  U Patzold; U Wurster; K Mardt; M Schiemann
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

3.  Adenosine deaminase and 5'nucleotidase activities in peripheral blood T cells of multiple sclerosis patients.

Authors:  S Vivekanandhan; C C Soundararajan; M Tripathi; M C Maheshwari
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

4.  Modulation of immunity in multiple sclerosis: a double-blind levamisole-placebo controlled study in 85 patients.

Authors:  R E Gonsette; L Demonty; P Delmotte; J Decree; W de Cock; H Verhaeghen; J Symoens
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.